Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)

Summary

The purpose of this study is to evaluate whether therapy with MORAb-004 is effective and safe in the treatment of metastatic, colorectal cancer.

Timeline

Start

2012-03-27

Primary completion

2013-10-20

Completion

2013-10-20

Outcome

Outcome not reported

Stopped: “By the sponsor at the end of Stage 1 due to futility.”

Drugs

Indications